Reblozyl 75 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F0BAP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,994
Award facts
- Contract value 100% obligated
- $25,993.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 15, 2026, for Reblozyl 75 mg vials with a ceiling value of $25,993.83 under firm fixed pricing.
Place of performance is Conshohocken, PA. The order is due for ultimate completion on May 6, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F0BAP?
SPE2DR26F0BAP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 15, 2026.
How much is contract SPE2DR26F0BAP worth?
The government has obligated $25,994 on SPE2DR26F0BAP.
Is contract SPE2DR26F0BAP an order under another contract?
Yes. SPE2DR26F0BAP is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F0BAP competed?
The extent of competition for SPE2DR26F0BAP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award